CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
126.08
0.72%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.19
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Quest Diagnostics Inc ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 127
Open* 126.6
1-Year Change* -9.4%
Day's Range* 125.54 - 127.47
52 wk Range 119.59-150.57
Average Volume (10 days) 1.00M
Average Volume (3 months) 19.94M
Market Cap 15.09B
P/E Ratio 20.14
Shares Outstanding 112.44M
Revenue 9.30B
EPS 6.67
Dividend (Yield %) 2.11577
Beta 0.91
Next Earnings Date Feb 1, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 26, 2024 126.08 1.39 1.11% 124.69 127.65 124.69
Feb 23, 2024 126.97 2.25 1.80% 124.72 127.14 124.72
Feb 22, 2024 125.20 -0.59 -0.47% 125.79 126.07 123.95
Feb 21, 2024 126.62 3.35 2.72% 123.27 126.72 123.09
Feb 20, 2024 123.72 0.04 0.03% 123.68 124.85 122.93
Feb 16, 2024 123.89 -0.65 -0.52% 124.54 125.75 123.44
Feb 15, 2024 125.64 -0.96 -0.76% 126.60 128.76 125.09
Feb 14, 2024 127.58 0.50 0.39% 127.08 128.50 126.41
Feb 13, 2024 127.77 -1.80 -1.39% 129.57 130.39 127.10
Feb 12, 2024 129.98 3.92 3.11% 126.06 130.05 125.34
Feb 9, 2024 126.67 0.92 0.73% 125.75 127.40 125.68
Feb 8, 2024 126.42 0.18 0.14% 126.24 126.81 124.65
Feb 7, 2024 127.29 -0.08 -0.06% 127.37 128.93 126.46
Feb 6, 2024 126.11 2.65 2.15% 123.46 126.73 122.95
Feb 5, 2024 123.69 -0.01 -0.01% 123.70 124.81 122.92
Feb 2, 2024 124.87 -1.05 -0.83% 125.92 126.59 123.62
Feb 1, 2024 126.50 3.17 2.57% 123.33 129.40 122.57
Jan 31, 2024 128.26 -0.62 -0.48% 128.88 129.85 127.90
Jan 30, 2024 128.73 0.47 0.37% 128.26 129.69 128.14
Jan 29, 2024 129.23 -0.03 -0.02% 129.26 129.83 128.74

Quest Diagnostics Events

Time (UTC) Country Event
Thursday, April 25, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Quest Diagnostics Inc Earnings Release
Q1 2024 Quest Diagnostics Inc Earnings Release

Forecast

-

Previous

-
Thursday, May 16, 2024

Time (UTC)

14:30

Country

US

Event

Quest Diagnostics Inc Annual Shareholders Meeting
Quest Diagnostics Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 9883 10788 9437 7726 7531
Revenue 9883 10788 9437 7726 7531
Cost of Revenue, Total 6418 6510 5720 5002 4870
Gross Profit 3465 4278 3717 2724 2661
Total Operating Expense 8455 8407 7466 6495 6430
Selling/General/Admin. Expenses, Total 1818 1680 1509 1403 1359
Depreciation / Amortization 120 103 103 96 90
Unusual Expense (Income) 92 116 134 90 126
Other Operating Expenses, Total 7 -2 -96 -15
Operating Income 1428 2381 1971 1231 1101
Interest Income (Expense), Net Non-Operating -193 -151 -163 -175 -167
Other, Net 369 76 20 -8
Net Income Before Taxes 1235 2599 1884 1076 926
Net Income After Taxes 971 2002 1424 829 730
Minority Interest -69 -85 -68 -48 -52
Equity In Affiliates 44 78 75 57 44
Net Income Before Extra. Items 946 1995 1431 838 722
Total Extraordinary Items 0 20 14
Net Income 946 1995 1431 858 736
Total Adjustments to Net Income -4 -7 -6 -3 -3
Income Available to Common Excl. Extra. Items 942 1988 1425 835 719
Income Available to Common Incl. Extra. Items 942 1988 1425 855 733
Diluted Net Income 942 1988 1425 855 733
Diluted Weighted Average Shares 118 128 136 136 139
Diluted EPS Excluding Extraordinary Items 7.98305 15.5312 10.4779 6.13971 5.17266
Dividends per Share - Common Stock Primary Issue 2.6 2.42 2.21 2.12 1.95
Diluted Normalized EPS 8.59605 16.2293 11.2227 6.64956 5.88727
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total revenue 2295 2338 2331 2333 2486
Revenue 2295 2338 2331 2333 2486
Cost of Revenue, Total 1539 1546 1550 1556 1612
Gross Profit 756 792 781 777 874
Total Operating Expense 1953 1990 2026 2198 2094
Selling/General/Admin. Expenses, Total 376 409 430 531 457
Depreciation / Amortization 27 28 26 39 27
Unusual Expense (Income) 6 7 19 51 13
Operating Income 342 348 305 135 392
Interest Income (Expense), Net Non-Operating -40 -37 -35 -32 -33
Other, Net -3 6 7 6 -8
Net Income Before Taxes 299 317 277 109 351
Net Income After Taxes 231 242 212 113 270
Minority Interest -12 -14 -15 -15 -20
Equity In Affiliates 6 7 5 3 6
Net Income Before Extra. Items 225 235 202 101 256
Net Income 225 235 202 101 256
Total Adjustments to Net Income -2 -1 -1 0 -2
Income Available to Common Excl. Extra. Items 223 234 201 101 254
Income Available to Common Incl. Extra. Items 223 234 201 101 254
Diluted Net Income 223 234 201 101 254
Diluted Weighted Average Shares 114 114 113 115 118
Diluted EPS Excluding Extraordinary Items 1.95614 2.05263 1.77876 0.87826 2.15254
Dividends per Share - Common Stock Primary Issue 0.71 0.71 0.66 0.66 0.66
Diluted Normalized EPS 1.9968 2.09951 1.90745 1.16652 2.23729
Other Operating Expenses, Total 5 0 1 21 -15
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 1898 2741 3058 2490 1390
Cash and Short Term Investments 315 872 1158 1192 135
Cash & Equivalents 315 872 1158 1192 135
Total Receivables, Net 1195 1438 1523 1063 1012
Accounts Receivable - Trade, Net 1195 1438 1520 1063 1012
Total Inventory 192 208 223 123 99
Prepaid Expenses 196 223 154 112 144
Other Current Assets, Total
Total Assets 12837 13611 14026 12843 11003
Property/Plant/Equipment, Total - Net 2351 2304 2231 1971 1288
Property/Plant/Equipment, Total - Gross 5688 5392 5223 4747 3970
Accumulated Depreciation, Total -3337 -3088 -2992 -2776 -2682
Goodwill, Net 7220 7095 6873 6619 6563
Intangibles, Net 1092 1167 1167 1121 1207
Long Term Investments 132 141 521 482 436
Other Long Term Assets, Total 144 163 176 160 119
Total Current Liabilities 1551 1753 1776 1990 1485
Accounts Payable 324 357 446 263 222
Accrued Expenses 1034 1189 1056 730 599
Notes Payable/Short Term Debt 92 116 153 88 98
Current Port. of LT Debt/Capital Leases 2 2 2 804 464
Other Current Liabilities, Total 99 89 119 105 102
Total Liabilities 6944 7167 7267 7202 5787
Total Long Term Debt 3978 4010 4013 3966 3429
Long Term Debt 3971 3985 3988 3936 3429
Minority Interest 114 118 132 122 128
Other Liabilities, Total 1006 1286 1346 1124 745
Total Equity 5893 6444 6759 5641 5216
Common Stock 2 2 2 2 2
Additional Paid-In Capital 2295 2260 2841 2722 2667
Retained Earnings (Accumulated Deficit) 8290 7649 9303 8174 7602
Treasury Stock - Common -4673 -3453 -5366 -5218 -4996
Other Equity, Total -22 -15 -29 -47 -59
Total Liabilities & Shareholders’ Equity 12837 13611 14026 12843 11003
Total Common Shares Outstanding 111 119 133 133 135
Unrealized Gain (Loss) 1 1 8 8 0
Capital Lease Obligations 7 25 25 30
Deferred Income Tax 295
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 1815 1733 1814 1898 2334
Cash and Short Term Investments 143 126 175 315 700
Cash & Equivalents 143 126 175 315 700
Total Receivables, Net 1281 1235 1254 1195 1280
Accounts Receivable - Trade, Net 1281 1235 1254 1195 1280
Total Inventory 184 184 190 192 183
Prepaid Expenses 207 188 195 196 171
Total Assets 13482 13425 12794 12837 13223
Property/Plant/Equipment, Total - Net 2437 2425 2384 2351 2314
Goodwill, Net 7732 7733 7241 7220 7190
Intangibles, Net 1219 1247 1077 1092 1115
Long Term Investments 130 135 128 132 138
Other Long Term Assets, Total 149 152 150 144 132
Total Current Liabilities 1618 1875 1355 1551 1602
Payable/Accrued 1157 1201 1198 1396 1447
Accrued Expenses 157 156 155 153 153
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 304 518 2 2 2
Total Liabilities 7057 7176 6744 6944 6988
Total Long Term Debt 3946 3777 3975 3978 3980
Long Term Debt 3946 3777 3975 3978 3980
Minority Interest 114 115 115 114 114
Other Liabilities, Total 1379 1409 1299 1301 1292
Total Equity 6425 6249 6050 5893 6235
Common Stock 2 2 2 2 2
Additional Paid-In Capital 2302 2284 2266 2295 2272
Retained Earnings (Accumulated Deficit) 8711 8566 8412 8290 8263
Treasury Stock - Common -4570 -4587 -4612 -4673 -4271
Other Equity, Total -20 -16 -18 -21 -31
Total Liabilities & Shareholders’ Equity 13482 13425 12794 12837 13223
Total Common Shares Outstanding 112 112 112 111 114
Capital Lease Obligations
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 1015 2080 1499 906 788
Cash From Operating Activities 1718 2233 2005 1243 1200
Cash From Operating Activities 437 408 361 329 309
Deferred Taxes 1 -57 85 15 73
Non-Cash Items 146 -285 38 -42 79
Cash Taxes Paid 283 709 360 202 84
Cash Interest Paid 156 159 201 192 174
Changes in Working Capital 119 87 22 35 -49
Cash From Investing Activities -543 21 -772 -411 -801
Capital Expenditures -404 -403 -418 -400 -383
Other Investing Cash Flow Items, Total -139 424 -354 -11 -418
Cash From Financing Activities -1732 -2540 -1267 225 -401
Financing Cash Flow Items -140 -159 -29 -87 -36
Total Cash Dividends Paid -305 -309 -297 -286 -266
Issuance (Retirement) of Stock, Net -1285 -2070 -136 -234 -223
Issuance (Retirement) of Debt, Net -2 -2 -805 832 124
Net Change in Cash -557 -286 -34 1057 -2
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 217 1015 899 623 373
Cash From Operating Activities 94 1718 1384 882 480
Cash From Operating Activities 107 437 321 213 106
Deferred Taxes -4 1 45 -20 -43
Non-Cash Items 26 146 93 71 22
Cash Taxes Paid 33 283 187 182 23
Cash Interest Paid 32 156 110 78 32
Changes in Working Capital -252 119 26 -5 22
Cash From Investing Activities -158 -543 -369 -251 -169
Capital Expenditures -127 -404 -257 -139 -63
Other Investing Cash Flow Items, Total -31 -139 -112 -112 -106
Cash From Financing Activities -76 -1732 -1187 -713 -471
Financing Cash Flow Items -27 -140 -105 -55 -33
Total Cash Dividends Paid -74 -305 -230 -152 -74
Issuance (Retirement) of Stock, Net 25 -1285 -851 -505 -363
Issuance (Retirement) of Debt, Net 0 -2 -1 -1 -1
Net Change in Cash -140 -557 -172 -82 -160
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 12.1773 13691518 51389 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 6.121 6882132 -106151 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.92 5531770 -144188 2023-06-30 LOW
Victory Capital Management Inc. Investment Advisor/Hedge Fund 2.876 3233625 97425 2023-06-30 LOW
American Century Investment Management, Inc. Investment Advisor/Hedge Fund 2.8162 3166355 437539 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.1549 2422912 72447 2023-06-30 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 2.0277 2279846 365292 2023-06-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.7705 1990673 -30178 2023-06-30 LOW
Grantham Mayo Van Otterloo & Co LLC Investment Advisor/Hedge Fund 1.4216 1598366 100333 2023-06-30 LOW
Wells Fargo Advisors Research Firm 1.3561 1524743 -9476 2023-06-30 LOW
Davis Selected Advisers, L.P. Investment Advisor/Hedge Fund 1.3465 1513888 -4864 2023-06-30 LOW
Invesco Capital Management LLC Investment Advisor 1.323 1487550 -218185 2023-06-30 LOW
T. Rowe Price Associates, Inc. Investment Advisor 1.2244 1376675 1375958 2023-06-30 LOW
BlackRock Asset Management Ireland Limited Investment Advisor 1.1655 1310457 -65782 2023-06-30 LOW
JP Morgan Asset Management Investment Advisor 1.1047 1242049 47460 2023-06-30 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 1.0801 1214438 2960 2023-06-30 LOW
LSV Asset Management Investment Advisor 0.9979 1121957 -100700 2023-06-30 LOW
Nordea Funds Oy Investment Advisor 0.9126 1026027 32105 2023-06-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.8949 1006215 50444 2022-12-31 LOW
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.8736 982190 -11941 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Quest Diagnostics Company profile

Founded in 1967, Quest Diagnostics (DGX) is the leading global provider of diagnostic information services. Headquartered in Madison, New Jersey, the company has a team of 43,000 employees that operate 2,200 patient service centres across the country. Annually, Quest serves one in three adult Americans and half the hospitals and physicians in the USA. Quest Diagnostics delivers diagnostic testing services for neurological disorders, cardiovascular disease, infectious diseases and cancer. With an annual revenue of $7.5 billion the company is included to the S&P 500 index. The Quest Diagnostics share price (DGX) is set and traded on the New York Stock Exchange (NYSE).
Industry: Healthcare Facilities & Services (NEC)

500 Plaza Drive
SECAUCUS
NEW JERSEY 07094
US

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

Gold

2,038.53 Price
+0.370% 1D Chg, %
Long position overnight fee -0.0189%
Short position overnight fee 0.0106%
Overnight fee time 22:00 (UTC)
Spread 0.30

BTC/USD

56,711.60 Price
+3.460% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

XRP/USD

0.56 Price
+1.400% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

US100

17,978.70 Price
+0.400% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading